about
Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling scienc...
Read More
34.10
-0.54
(-1.56%)
55,304
XNAS Volume
XNAS 28 Jan, 2026 4:30 PM (EST)
Low Financial Strength
Expensive Valuation
Technically Moderately Bullish
Momentum Trap
These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution
View Similar
Embed DVM
Galapagos NV (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..